Go to the top

Dr. Lopes Among First Doctors to Access New Brain Clot Integration and Retrieval Device

Posted on August 12, 2012

Trevo® Pro Retrieval System is the first device featuring Stentriever® Technology specifically for stroke and for maximizing clot integration. Image: Stryker Neurovascular

Demetrius Lopes, MD, is one of the first doctors in the Midwest region to have access to the latest technology from Stryker Neurovascular for removing clots from the brain in patients experiencing acute ischemic stroke. The Trevo® Pro Retriever has been granted market clearance by the FDA and is the first device to use proprietary Stentriever® Technology, designed for optimized clot integration and retrieval.

Stroke is the fourth leading cause of death in the United States and a devastating disease for patients and their loved ones. Major strokes in which a blood clot lodges in one of the larger vessels of the brain have a poor prognosis if not treated quickly. Next generation devices like the Trevo® Pro Retriever are helping physicians to rapidly restore blood flow to the brain, faster and more effectively to allow patients a better chance to return to normal lives.

The Trevo® Pro Retriever demonstrated strong clinical results in the TREVO 2 clinical trial compared to the Merci Retriever®, the previous generation of clot removal devices. This new technology has the highest rate of revascularization and good clinical outcomes in a randomized embolectomy stroke device trial.

About Trevo Pro Retrieval System

The Trevo® Pro Retrieval System, developed by Concentric Medical, Inc., now owned by Stryker, is an innovative, thrombus retrieval system that is delivered to the site of occlusion through a microcatheter that is inserted through a small puncture in the femoral artery. Using proprietary Stentriever® Technology, the Trevo® Pro Retriever is designed to integrate into blood clots and remove them from the body, thereby restoring blood flow to the brain.

About Acute Ischemic Stroke

Stroke is the fourth leading cause of death in the developed world and the leading cause of serious long‐term disability. Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain. The goal of intervention is to remove the thrombus from the vessel in the brain, thereby restoring blood flow to the brain. In the United States there are currently a limited number of FDA-cleared devices for removing the occlusion from the brain. Retrieval technologies, such as the new Trevo® Pro Retrieval System, create a departure from the historic method of caring for stroke patients and offer physicians and patients new options for stroke intervention.